Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Acute inferior ST elevation myocardial infarction

Locations
Other Locations
Egypt
Ain Shams University
RECRUITING
Cairo
Contact Information
Primary
Mohamed G Elewa, MD
mdgamal92@gmail.com
+201019811895
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 150
Treatments
Active_comparator: Atropine arm
This group will receive intravenous atropine 1 mg immediately before wire crossing
Placebo_comparator: Placebo arm
This group will receive intravenous normal saline immediately before wire crossing
Sponsors
Leads: Ain Shams University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials